| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4143939 | Anales de Pediatría | 2007 | 7 Pages |
Abstract
In view of our results, we believe the following measures are essential to improve the prognosis of MSUD: inclusion of this disease in Expanded Neonatal Screening Programs with early samples (at 2-3 days of life); aggressive treatment in the initial phase and during acute decompensations; strict metabolic control to prevent crises, monitoring of branched-chain amino acids (dried blood spot sample), and maintenance of long term plasma leucine levels below 300 μmol/L.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
M.L. Couce Pico, D.E. Castiñeiras Ramos, M.D. Bóveda Fontán, A.J. Iglesias RodrÃguez, J.A. Cocho De Juan, J.M. Fraga Bermúdez,